Riociguat is Safe and Effective Way of Treating CTEPH Treatment Over Long Term, Review Finds
News, Pulmonary Hypertension
Results from the ongoing Phase 3 study known as CHEST-2 support the long-term use of riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH). The findings are detailed in the study, “Predictors ... Read more